![](/img/cover-not-exists.png)
The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin
Y.-L. He, R. Sabo, J. Campestrini, Y. Wang, M. Ligueros-Saylan, K. C. Lasseter, S. C. Dilzer, D. Howard, W. P. DoleVolume:
63
Language:
english
Pages:
10
DOI:
10.1007/s00228-007-0312-6
Date:
July, 2007
File:
PDF, 240 KB
english, 2007